DexCom Inc (DXCM)

DexCom Inc (DXCM) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $29.6B; returns 1 day -0.5%, 1 week -9.4%, 1 year +9.7%.

DexCom Inc. (DXCM) is a leading medical device company primarily focused on the design, development, and commercialization of Continuous Glucose Monitoring (CGM) systems. The company's business model largely operates on a "razor-and-razor-blade" approach, with the vast majority of its revenue (approximately 97% in Q3 2025) derived from the recurring sales of disposable CGM sensors.

Groups DXCM belongs to

• Shrinking Share Count
• S&P 500
• Continuous Glucose Monitoring
• Medical Devices
• Healthcare
• Type 1 Diabetes
• Metabolic Disorders
• Healthcare Technology
• Life Sciences
• Health Diagnostics and Imaging
• AI in Healthcare
• Medical Disposables

DXCM financial model: income statement, cash flow and balance sheet